- Home
- CURI vs OABI Comparison
CURI vs OABI Comparison
Compare CURI & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CURI
- OABI
- Stock Information
- Founded
- CURI 2008
- OABI 2012
- Country
- CURI United States
- OABI United States
- Employees
- CURI N/A
- OABI N/A
- Industry
- CURI Movies/Entertainment
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- CURI Consumer Discretionary
- OABI Health Care
- Exchange
- CURI Nasdaq
- OABI Nasdaq
- Market Cap
- CURI 264.7M
- OABI 228.9M
- IPO Year
- CURI N/A
- OABI N/A
- Fundamental
- Price
- CURI $4.85
- OABI $1.64
- Analyst Decision
- CURI Strong Buy
- OABI Strong Buy
- Analyst Count
- CURI 2
- OABI 3
- Target Price
- CURI $5.75
- OABI $6.67
- AVG Volume (30 Days)
- CURI 613.5K
- OABI 397.8K
- Earning Date
- CURI 11-05-2025
- OABI 11-11-2025
- Dividend Yield
- CURI 6.60%
- OABI N/A
- EPS Growth
- CURI N/A
- OABI N/A
- EPS
- CURI N/A
- OABI N/A
- Revenue
- CURI $60,840,000.00
- OABI $23,027,000.00
- Revenue This Year
- CURI $34.06
- OABI N/A
- Revenue Next Year
- CURI $11.70
- OABI $44.99
- P/E Ratio
- CURI N/A
- OABI N/A
- Revenue Growth
- CURI 11.02
- OABI 6.05
- 52 Week Low
- CURI $1.47
- OABI $1.22
- 52 Week High
- CURI $7.15
- OABI $4.87
- Technical
- Relative Strength Index (RSI)
- CURI 61.55
- OABI 43.98
- Support Level
- CURI $4.31
- OABI $1.55
- Resistance Level
- CURI $4.71
- OABI $1.73
- Average True Range (ATR)
- CURI 0.22
- OABI 0.10
- MACD
- CURI 0.04
- OABI 0.00
- Stochastic Oscillator
- CURI 98.41
- OABI 30.59
About CURI CuriosityStream Inc.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.